Literature DB >> 21392180

Rapamycin attenuates the expression of cocaine-induced place preference and behavioral sensitization.

Jeffrey Bailey1, Dzwokai Ma, Karen K Szumlinski.   

Abstract

The mammalian target of rapamycin (mTOR) is a serine-threonine kinase that controls global protein synthesis, in part, by modulating translation initiation, a rate-limiting step for many mRNAs. Previous studies implicate mTOR in regulating stimulant-induced sensitization and antidepressive-like behavior in rodents, as well as drug craving in abstinent heroin addicts. To determine if signaling downstream of mTOR is affected by repeated cocaine administration in reward-associated brain regions, and if inhibition of mTOR alters cocaine-induced behavioral plasticity, C57BL/6J mice received four intraperitoneal (i.p.) injections of 15 mg/kg cocaine and levels of phosphorylated P70S6 kinase and ribosomal S6 protein-two translational regulators directly downstream of mTOR-were analyzed by immunoblotting across several brain regions. Cocaine place preference and locomotor sensitization were elicited by four pairings of cocaine with a distinct environment and the effects of mTOR inhibition were assessed by pre-treating the mice with 10 mg/kg rapamycin, 1 hour prior to: (1) each saline/cocaine conditioning session; (2) a post-conditioning test; or (3) a test for locomotor sensitization conducted at 3 weeks withdrawal. While systemic pre-treatment with 10 mg/kg rapamycin during conditioning failed to alter the development of a cocaine place preference or locomotor sensitization, pre-treatment prior to the post-conditioning test attenuated the expression of the place preference. Additionally, rapamycin pre-treatment prior to a cocaine challenge 3 weeks post-conditioning blocked the expression of the sensitized locomotor response. These findings suggest a role for mTOR activity, and perhaps translational control, in the expression of cocaine-induced place preference and locomotor sensitization.
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392180      PMCID: PMC3500570          DOI: 10.1111/j.1369-1600.2010.00311.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  39 in total

Review 1.  Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies.

Authors:  L J Vanderschuren; P W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  2000-08       Impact factor: 4.530

2.  Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons.

Authors:  Daniel Saal; Yan Dong; Antonello Bonci; Robert C Malenka
Journal:  Neuron       Date:  2003-02-20       Impact factor: 17.173

3.  Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization.

Authors:  Emanuela Izzo; Rémi Martin-Fardon; George F Koob; Friedbert Weiss; Pietro Paolo Sanna
Journal:  Nat Neurosci       Date:  2002-12       Impact factor: 24.884

4.  BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development.

Authors:  Gerhard M Schratt; Elizabeth A Nigh; Wen G Chen; Linda Hu; Michael E Greenberg
Journal:  J Neurosci       Date:  2004-08-18       Impact factor: 6.167

Review 5.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

6.  A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus.

Authors:  Shao Jun Tang; Gerald Reis; Hyejin Kang; Anne-Claude Gingras; Nahum Sonenberg; Erin M Schuman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

7.  Accumbens Homer2-mediated signaling: a factor contributing to mouse strain differences in alcohol drinking?

Authors:  S P Goulding; I Obara; K D Lominac; A T Gould; B W Miller; M Klugmann; K K Szumlinski
Journal:  Genes Brain Behav       Date:  2010-10-18       Impact factor: 3.449

8.  Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving.

Authors:  Jeffrey W Grimm; Lin Lu; Teruo Hayashi; Bruce T Hope; Tsung-Ping Su; Yavin Shaham
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

9.  A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal.

Authors:  Lin Lu; Jack Dempsey; Shirley Y Liu; Jennifer M Bossert; Yavin Shaham
Journal:  J Neurosci       Date:  2004-02-18       Impact factor: 6.167

10.  Homer 2 tunes G protein-coupled receptors stimulus intensity by regulating RGS proteins and PLCbeta GAP activities.

Authors:  Dong Min Shin; Marlin Dehoff; Xiang Luo; Shin Hyeok Kang; Jiangchen Tu; Surendra K Nayak; Elliott M Ross; Paul F Worley; Shmuel Muallem
Journal:  J Cell Biol       Date:  2003-07-14       Impact factor: 10.539

View more
  24 in total

1.  Essential role of D1R in the regulation of mTOR complex1 signaling induced by cocaine.

Authors:  Laurie P Sutton; Marc G Caron
Journal:  Neuropharmacology       Date:  2015-08-24       Impact factor: 5.250

2.  Withdrawal From Cocaine Self-administration Alters the Regulation of Protein Translation in the Nucleus Accumbens.

Authors:  Michael T Stefanik; Mike Milovanovic; Craig T Werner; John C G Spainhour; Marina E Wolf
Journal:  Biol Psychiatry       Date:  2018-02-23       Impact factor: 13.382

3.  Response of the Ubiquitin-Proteasome System to Memory Retrieval After Extended-Access Cocaine or Saline Self-Administration.

Authors:  Craig T Werner; Mike Milovanovic; Daniel T Christian; Jessica A Loweth; Marina E Wolf
Journal:  Neuropsychopharmacology       Date:  2015-06-05       Impact factor: 7.853

4.  Protein Translation in the Nucleus Accumbens Is Dysregulated during Cocaine Withdrawal and Required for Expression of Incubation of Cocaine Craving.

Authors:  Craig T Werner; Michael T Stefanik; Mike Milovanovic; Aaron Caccamise; Marina E Wolf
Journal:  J Neurosci       Date:  2018-02-05       Impact factor: 6.167

5.  VTA mTOR Signaling Regulates Dopamine Dynamics, Cocaine-Induced Synaptic Alterations, and Reward.

Authors:  Xiaojie Liu; Yan Li; Laikang Yu; Casey R Vickstrom; Qing-Song Liu
Journal:  Neuropsychopharmacology       Date:  2017-10-17       Impact factor: 7.853

6.  Rottlerin impairs the formation and maintenance of psychostimulant-supported memory.

Authors:  Tien You Liao; Wen-Yu Tzeng; Hsin-Hua Wu; Chianfang G Cherng; Ching-Yi Wang; Sherry S-J Hu; Lung Yu
Journal:  Psychopharmacology (Berl)       Date:  2016-03-10       Impact factor: 4.530

7.  PI3K activation within ventromedial prefrontal cortex regulates the expression of drug-seeking in two rodent species.

Authors:  Karen K Szumlinski; Alexis W Ary; Christina B Shin; Melissa G Wroten; Justin Courson; Bailey W Miller; Micaela Ruppert-Majer; John W Hiller; John R Shahin; Osnat Ben-Shahar; Tod E Kippin
Journal:  Addict Biol       Date:  2018-11-18       Impact factor: 4.280

8.  mTORC1 inhibition in the nucleus accumbens 'protects' against the expression of drug seeking and 'relapse' and is associated with reductions in GluA1 AMPAR and CAMKIIα levels.

Authors:  Morgan H James; Rikki K Quinn; Lin Kooi Ong; Emily M Levi; Janine L Charnley; Doug W Smith; Phillip W Dickson; Christopher V Dayas
Journal:  Neuropsychopharmacology       Date:  2014-01-28       Impact factor: 7.853

9.  Metabotropic glutamate receptor I (mGluR1) antagonism impairs cocaine-induced conditioned place preference via inhibition of protein synthesis.

Authors:  Fei Yu; Peng Zhong; Xiaojie Liu; Dalong Sun; Hai-Qing Gao; Qing-Song Liu
Journal:  Neuropsychopharmacology       Date:  2013-01-24       Impact factor: 7.853

10.  Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.

Authors:  Jeffrey J Liu; Yi-Ting Chiu; Kelly M DiMattio; Chongguang Chen; Peng Huang; Taylor A Gentile; John W Muschamp; Alan Cowan; Matthias Mann; Lee-Yuan Liu-Chen
Journal:  Neuropsychopharmacology       Date:  2018-07-20       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.